Approval · Notice of Compliance 31053 · 2023
INVOKAMET: Notice of Compliance 31053
Issued June 23, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31053
- Date
- June 23, 2023
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph / Product Monograph reformatted to the Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INVOKAMET | Not yet assigned | — |
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per TAB
- CANAGLIFLOZIN 50 MG per TAB
- METFORMIN HYDROCHLORIDE 1,000 MG per TAB
- CANAGLIFLOZIN 150 MG per TAB